{
  "run": {
    "generated_at": "2026-01-04T09:05:30.980318+00:00",
    "input_receipt": "/Users/fahadkiani/Desktop/development/crispr-assistant-main/publications/02-trial-matching/receipts/latest/real_world_tcga_ov_validation.json",
    "n_total_with_os": 571,
    "threshold": {
      "best_fit_gt": 0.5
    }
  },
  "groups": {
    "matchable": {
      "n": 269,
      "n_events": 165,
      "median_days": 1330.0
    },
    "non_matchable": {
      "n": 302,
      "n_events": 176,
      "median_days": 1471.0
    }
  },
  "km": {
    "logrank": {
      "test_statistic": 1.1298870576659712,
      "p_value": 0.28779943096791294
    }
  },
  "cox": {
    "model": "univariate_matchable",
    "hazard_ratio": 1.1220703730199935,
    "p_value": 0.28834691058935635,
    "interpretation": {
      "hr_lt_1_better_survival_for_matchable": false
    }
  },
  "notes": [
    "This tests association with OS, not treatment benefit. TCGA-OV is not a trial enrollment dataset.",
    "Group definition is purely best_fit > 0.5 against the 59-trial MoA bank."
  ]
}